Behind the Mystery
A specialized, recurring segment devoted to rare and genetic diseases, Behind the Mystery highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. We clarify the often-complex issues by offering easy-to-understand explanations from top experts in the field. Our goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies, while giving voices to the patients, families, and advocates affected via our national television platform.
Novocure®, a global oncology company, is working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, tumor treating fields.
Learning more about two diseases that affect the brain: glioblastoma and schizophrenia.
Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.
Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.
Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.
Glioblastoma (GBM) is rare brain tumor that is difficult to treat and has a poor prognosis.
Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.
There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients.
Friedreich’s Ataxia is a progressive and debilitating neurological disorder. It's important to recognize symptoms and obtain an early diagnosis to properly manage the condition.